258 related articles for article (PubMed ID: 8897580)
1. Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.
Ryall RL
Pediatr Nephrol; 1996 Oct; 10(5):656-66. PubMed ID: 8897580
[TBL] [Abstract][Full Text] [Related]
2. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
Atmani F; Glenton PA; Khan SR
Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation.
Webber D; Radcliffe CM; Royle L; Tobiasen G; Merry AH; Rodgers AL; Sturrock ED; Wormald MR; Harvey DJ; Dwek RA; Rudd PM
FEBS J; 2006 Jul; 273(13):3024-37. PubMed ID: 16817853
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitors in calcium oxalate crystals].
Suzuki K
Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):411-20. PubMed ID: 10349299
[No Abstract] [Full Text] [Related]
5. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
6. Calcium phosphate crystal-associated proteins: alpha-2-HS-glycoprotein, prothrombin fragment 1 and osteopontin.
Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
Int J Urol; 2001 Aug; 8(8):S58-62. PubMed ID: 11555022
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.
Khan A
Int Urol Nephrol; 2018 May; 50(5):799-806. PubMed ID: 29569213
[TBL] [Abstract][Full Text] [Related]
8. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
Kumar V; Farell G; Lieske JC
J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
[TBL] [Abstract][Full Text] [Related]
9. Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
Mol Urol; 2000; 4(4):383-90. PubMed ID: 11156706
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic urinary stone disease: possible polygenic aetiological factors.
Watts RW
QJM; 2005 Apr; 98(4):241-6. PubMed ID: 15781479
[No Abstract] [Full Text] [Related]
11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
12. Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis.
Grover PK; Thurgood LA; Ryall RL
Am J Physiol Renal Physiol; 2007 May; 292(5):F1396-403. PubMed ID: 17267387
[TBL] [Abstract][Full Text] [Related]
13. Partial biochemical and physicochemical characterization of organic macromolecules in urine from patients with renal stones and control subjects.
Kitamura T; Zerwekh JE; Pak CY
Kidney Int; 1982 Feb; 21(2):379-86. PubMed ID: 7070000
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
Grover PK; Moritz RL; Simpson RJ; Ryall RL
Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
[TBL] [Abstract][Full Text] [Related]
15. Significance of glycosaminoglycans for the formation of calcium oxalate stones.
Hesse A; Wuzel H; Vahlensieck W
Am J Kidney Dis; 1991 Apr; 17(4):414-9. PubMed ID: 2008909
[TBL] [Abstract][Full Text] [Related]
16. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
17. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin and stone formation.
Asakura H
Int J Urol; 2002 Feb; 9(2):108; discussion 108-9. PubMed ID: 12028301
[No Abstract] [Full Text] [Related]
19. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation.
Mo L; Huang HY; Zhu XH; Shapiro E; Hasty DL; Wu XR
Kidney Int; 2004 Sep; 66(3):1159-66. PubMed ID: 15327412
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of calcium phosphate-associated proteins on calcium oxalate crystallization: alpha2-HS-glycoprotein, prothrombin-F1 and osteopontin.
Nishio S; Iseda T; Takeda H; Iwata H; Yokoyama M
BJU Int; 2000 Sep; 86(4):543-8. PubMed ID: 10971289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
